IP Library Granted Patent US 8,404,809
Granted Patent B2
US 8,404,809 · App. 12/605,028 · Granted Mar 26, 2013

Glycopegylated factor IX

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,404,809
App. No.
12/605,028
Granted
Mar 26, 2013
Kind
B2
Abstract

Conjugates between Factor IX and PEG moieties are disclosed in the present application. The conjugates are linked via a glycosyl linking group interposed between and covalently attached to the peptide and the modifying group. Conjugates are formed from glycosylated peptides by the action of a glycosyltransferase. The glycosyltransferase ligates a modified sugar moiety onto a glycosyl residue on the peptide. Also provided are methods for preparing the conjugates, methods for treating various disease conditions with the conjugates, and pharmaceutical formulations including the conjugates.

Claims (10)

1. A PEGylated Factor IX protein comprising SEQ ID NO:1 and a glycosyl linking group-linked polyethylene glycol moiety attached to Asn 157, Asn 167 or combinations thereof of SEQ ID NO:1 and having a composition according to the formula:

wherein

R 2 is COOH;

R 3 is H;

R 4 is OH;

D is OH; and

G is R 1 -L-

wherein

L is a linker comprising C(O)NH; and

R′ is a branched poly(ethylene glycol) having a core glycerol moiety and a molecular weight of about 40 kD.